characteristics.text: 2011-09-30T17:00:32Z
characteristics.characteristic: ENA-FIRST-PUBLIC
characteristics.text: 2018-03-08T15:26:55Z
characteristics.characteristic: ENA-LAST-UPDATE
characteristics.text: SAMEA1030495
characteristics.characteristic: External Id
characteristics.text: CRUK-CRI
characteristics.characteristic: INSDC center name
characteristics.text: 2011-09-30T17:00:32Z
characteristics.characteristic: INSDC first public
characteristics.text: 2018-03-08T15:26:55Z
characteristics.characteristic: INSDC last update
characteristics.text: public
characteristics.characteristic: INSDC status
characteristics.text: ERS035627
characteristics.characteristic: SRA accession
characteristics.text: PEO23
characteristics.ontologyTerms: http://www.ebi.ac.uk/efo/EFO_0002509
characteristics.characteristic: Submitter Id
characteristics.text: Resistant
characteristics.characteristic: cisplatin sensitivity
characteristics.text: human
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_9606
characteristics.characteristic: common name
characteristics.text: Ovarian cancer cell line PEO23
characteristics.characteristic: description
characteristics.text: Relapse
characteristics.ontologyTerms: http://www.ebi.ac.uk/efo/EFO_0004952
characteristics.characteristic: disease stage
characteristics.text: Homo sapiens
characteristics.characteristic: organism
characteristics.text: 3
characteristics.characteristic: patient number
characteristics.text: Homo sapiens
characteristics.characteristic: scientific_name